Biotech

All Articles

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has made a late access to the radioligand party, paying for 100 thousand euros ($ 110 millio...

F 2G rears $100M for 2nd attempt to obtain brand-new antifungal to market

.After F2G's initial try to acquire a new course of antifungal to market was wrecked due to the FDA,...

Moderna targets $1.1 B in R&ampD costs cuts, falls 5 systems amid success tensions

.Moderna has actually promised to cut R&ampD investing through $1.1 billion through 2027. The select...

Sanofi's $80M bank on Key dystrophy medication ends in phase 3 go under

.Simply 4 months after Sanofi bet $80 thousand in ahead of time cash money on Fulcrum Therapies' los...

Oncternal share sinks 60% amid unemployments, test terminations

.Cancer firm Oncternal Therapeutics is actually folding all its professional trials as well as givin...

Roche is actually keeping out hopes that its own injectable obesity possibility could inevitably show 25% weight management in late-stage test

.Roche is actually keeping out chances that its injectable excessive weight prospect might inevitabl...

Novo Nordisk barrages 'exceptional' weight management result for dual-acting dental drug in early test

.Novo Nordisk has lifted the cover on a phase 1 trial of its dental amylin and GLP-1 receptor co-ago...

AbbVie takes legal action against BeiGene over blood stream cancer cells medication trade secrets

.Simply a few brief full weeks after winning an FDA Fast lane tag for its investigational BTK degrad...

Lilly provides one-two hit with second tranche of beneficial information on every week insulin applicant

.Quickly after a good records drop for Eli Lilly's efsitora alfa, the Indianapolis-based firm is act...

BridgeBio cuts genetics therapy budget plan as clinical information disappoint

.BridgeBio Pharma is lowering its gene treatment budget and also pulling back coming from the method...